Literature DB >> 33351506

Intense Diffuse Uptake of 68Ga-FAPI-04 in the Breasts Found by PET/CT in a Patient With Advanced Nasopharyngeal Carcinoma.

Li-Juan Wang1, Yin Zhang, Hu-Bing Wu.   

Abstract

ABSTRACT: The physiological uptake of 68Ga-FAPI-04 due to the change of the internal environment is little known. We report the case of a 45-year-old woman who was highly suspected to have advanced nasopharyngeal carcinoma. 18F-FDG and 68Ga-FAPI-04 PET/CT was performed for evaluating the disease. Both PET and CT with different tracers detected the primary nasopharyngeal carcinoma and metastases in right neck lymph nodes, liver, and bones. To our surprise, intense diffuse uptake of 68Ga-FAPI-04 was found in both breasts, which might be due to the hormone stimulation because the patient received 68Ga-FAPi-04 PET/CT just at the period of ovulation.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33351506     DOI： 10.1097/RLU.0000000000003487

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  5 in total

1.  Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer.

Authors:  Umut Elboga; Ertan Sahin; Tulay Kus; Yusuf Burak Cayirli; Gokmen Aktas; Evren Uzun; Havva Yesil Cinkir; Fatih Teker; Ozlem Nuray Sever; Alper Aytekin; Latif Yilmaz; Aydin Aytekin; Ufuk Cimen; Vuslat Mumcu; Benan Kilbas; Y Zeki Çelen
Journal:  Ann Nucl Med       Date:  2021-08-26       Impact factor: 2.668

Review 2.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors:  Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-31       Impact factor: 10.057

3.  Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?

Authors:  Hessamoddin Roustaei; Zahra Kiamanesh; Emran Askari; Ramin Sadeghi; Kamran Aryana; Giorgio Treglia
Journal:  Contrast Media Mol Imaging       Date:  2022-02-22       Impact factor: 3.161

4.  Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts.

Authors:  Kongzhen Hu; Junqi Li; Lijuan Wang; Yong Huang; Li Li; Shimin Ye; Yanjiang Han; Shun Huang; Hubing Wu; Jin Su; Ganghua Tang
Journal:  Acta Pharm Sin B       Date:  2021-10-15       Impact factor: 11.413

5.  FAPI-04 Uptake in Healthy Tissues of Cancer Patients in 68Ga-FAPI-04 PET/CT Imaging.

Authors:  Cihan Gündoğan; Yunus Güzel; Canan Can; İhsan Kaplan; Halil Kömek
Journal:  Contrast Media Mol Imaging       Date:  2021-11-23       Impact factor: 3.161
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.